This is a clinical study to look at possible drug-drug interactions (DDIs) between antiretroviral therapy (ART - medication used to treat HIV) and feminizing hormone therapy (FHT - medications some trans women take as part of their transition).
With mixed emotions, I wish to inform my patients that I will be retiring from the full-time practice of medicine on October 1, 2022. I feel very fortunate in finding Dr. William Tsang to take over my practice on October 1, 2022. Many of you have already met Dr. Tsang when he cared for you during my recent vacations.
Aging well with HIV is a phrase that, in the not so distant past, could have seemed impossible. However, there have been huge advances in HIV prevention, treatment, and care over the last 20 years, giving people living with HIV the ability to live long, healthy lives. Despite more people now aging with HIV, little research has been done into exactly what it is like to grow older with the virus and especially the factors that enable people living with HIV to age well.
The CHANGE HIV study (CTN 314) is setting out to answer some of these unknowns.
Pre-exposure prophylaxis (or PrEP) is when people at risk for HIV take daily medicine to prevent HIV. PrEP can stop HIV from taking hold and spreading throughout your body. When taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use. PrEP is much less effective when it is not taken consistently.